1
|
Davi F, Gocke C, Smith S and Sklar J:
Lymphocytic progenitor cell origin and clonal evolution of human
B-lineage acute lymphoblastic leukemia. Blood. 88:609–621.
1996.PubMed/NCBI
|
2
|
Montemayor-Montoya JL, De León-Cantú RE,
Gómez-Almaguer D and Herrera-Garza JL: 3 cases of bone marrow
necrosis in acute leukemia. Rev Invest Clin. 49:295–298. 1997.(In
Spanish). PubMed/NCBI
|
3
|
Canet E, Zafrani L, Lambert J, Thieblemont
C, Galicier L, Schnell D, Raffoux E, Lengline E, Chevret S, Darmon
M and Azoulay E: Acute kidney injury in patients with newly
diagnosed high-grade hematological malignancies: Impact on
remission and survival. PLoS One. 8:e558702013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Moorman AV, Harrison CJ, Buck GA, Richards
SM, Secker-Walker LM, Martineau M, Vance GH, Cherry AM, Higgins RR,
Fielding AK, et al: Karyotype is an independent prognostic factor
in adult acute lymphoblastic leukemia (ALL): Analysis of
cytogenetic data from patients treated on the Medical Research
Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG)
2993 trial. Blood. 109:3189–3197. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Bernard C, Sick H, Boilletot A and
Oberling F: Bone marrow necrosis. acute microcirculation failure in
myelomonocytic leukemia. Arch Intern Med. 138:1567–1569. 1978.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Paydas S, Ergin M, Baslamisli F, Yavuz S,
Zorludemir S, Sahin B and Bolat FA: Bone marrow necrosis:
Clinicopathologic analysis of 20 cases and review of the
literature. Am J Hematol. 70:300–305. 2002. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lackner H, Strenger V, Sovinz P,
Beham-Schmid C, Pilhatsch A, Benesch M, Schwinger W, Ulreich R,
Schmidt S and Urban C: Bone marrow necrosis in a girl with
Hodgkin's disease. Support Care Cancer. 20:2231–2234. 2012.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Moritake H, Obara M, Sameshima N, Asada Y,
Komatsu H, Hyakuna N, Sugita K, Ishida Y, Kato M, Tanizawa A, et
al: Analysis of the molecular mechanism underlying bone marrow
necrosis with acute lymphoblastic leukemia. Int J Hematol.
102:349–356. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Seki Y, Koike T, Yano M, Aoki S, Hiratsuka
M, Fuse I and Aizawa Y: Bone marrow necrosis with dyspnea in a
patient with malignant lymphoma and plasma levels of
thrombomodulin, tumor necrosis factor-alpha, and D-dimer. Am J
Hematol. 70:250–253. 2002. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kellum JA, Lameire N, Aspelin P, Barsoum
RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A,
Levey AS, et al: Kidney Disease: Improving Global Outcomes (KDIGO)
Acute Kidney Injury Work Group: KDIGO clinical practice guideline
for acute kidney injury. Kidney Int Suppl. 2:1–138. 2012.
|
11
|
Abu-Alfa AK and Younes A: Tumor lysis
syndrome and acute kidney injury: Evaluation, prevention, and
management. Am J Kidney Dis. 55 5 Suppl 3:S1–S13; quiz S14-S19.
2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Soares M, Salluh JI, Carvalho MS, Darmon
M, Rocco JR and Spector N: Prognosis of critically ill patients
with cancer and acute renal dysfunction. J Clin Oncol.
24:4003–4010. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Canet E, Vincent F, Darmon M and Soares M:
Acute kidney injury in hematological patients. Curr Opin Crit Care.
21:549–558. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cairo MS and Bishop M: Tumour lysis
syndrome: New therapeutic strategies and classification. Br J
Haematol. 127:3–11. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Stapleton FB, Strother DR, Roy S III,
Wyatt RJ, McKay CP and Murphy SB: Acute renal failure at onset of
therapy for advanced stage Burkitt lymphoma and B cell acute
lymphoblastic lymphoma. Pediatrics. 82:863–869. 1988.PubMed/NCBI
|
16
|
Annemans L, Moeremans K, Lamotte M, Conde
Garcia J, van den Berg H, Myint H, Pieters R and Uyttebroeck A:
Incidence, medical resource utilisation and costs of hyperuricemia
and tumour lysis syndrome in patients with acute leukaemia and
non-Hodgkin's lymphoma in four European countries. Leuk Lymphoma.
44:77–83. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Coiffier B, Altman A, Pui CH, Younes A and
Cairo MS: Guidelines for the management of pediatric and adult
tumor lysis syndrome: An evidence-based review. J Clin Oncol.
26:2767–2778. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Oiwa K, Morita M, Kishi S, Okura M, Tasaki
T, Matsuda Y, Tai K, Hosono N, Ueda T and Yamauchi T: High risk of
tumor lysis syndrome in symptomatic patients with multiple myeloma
with renal dysfunction treated with bortezomib. Anticancer Res.
36:6655–6662. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kjellstrand CM, Cambell DC II, von
Hartitzsch B and Buselmeier TJ: Hyperuricemic acute renal failure.
Arch Intern Med. 133:349–359. 1974. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tsokos GC, Balow JE, Spiegel RJ and
Magrath IT: Renal and metabolic complications of undifferentiated
and lymphoblastic lymphomas. Medicine (Baltimore). 60:218–229.
1981. View Article : Google Scholar : PubMed/NCBI
|
21
|
Shimada M, Johnson RJ, May WS Jr,
Lingegowda V, Sood P, Nakagawa T, Van QC, Dass B and Ejaz AA: A
novel role for uric acid in acute kidney injury associated with
tumour lysis syndrome. Nephrol Dial Transplant. 24:2960–2964. 2009.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Prasada H: Sevelamer hydrochloride for
tumor lysis syndrome-related hyperphosphatemia. Indian Pediatr.
52:613–615. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Uprety D, Peterson A and Shah BK: Renal
failure secondary to leukemic infiltration of kidneys in CLL-a case
report and review of literature. Ann Hematol. 92:271–273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Spapen J, Fostier K, De Raeve H, Janssens
P and Spapen H: An unexpected complication of chronic
myelomonocytic leukemia: Severe renal failure due to malignant
tubulo-interstitial cell infiltration. Int J Nephrol Renovasc Dis.
9:1–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Lim SN, Joo YD, Lee KH, Kim DY, Lee JH,
Lee JH, Chi HS, Yun SC, Lee WS, Lee SM, et al: Long-term follow-up
of imatinib plus combination chemotherapy in patients with newly
diagnosed Philadelphia chromosome-positive acute lymphoblastic
leukemia. Am J Hematol. 90:1013–1020. 2015. View Article : Google Scholar : PubMed/NCBI
|